Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Cash from Discontinued Operations (2020 - 2021)

Serina Therapeutics (SER) has disclosed Cash from Discontinued Operations for 2 consecutive years, with 90000.0 as the latest value for Q1 2021.

  • Quarterly Cash from Discontinued Operations fell 151.14% to 90000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was 90000.0 through Dec 2021, changed N/A year-over-year, with the annual reading at 90000.0 for FY2021, 147.12% down from the prior year.
  • Cash from Discontinued Operations hit 90000.0 in Q1 2021 for Serina Therapeutics, up from 92000.0 in the prior quarter.
  • In the past five years, Cash from Discontinued Operations ranged from a high of 176000.0 in Q1 2020 to a low of 92000.0 in Q2 2020.